Log in
Enquire now
‌

US Patent 7597443 Wide viewing angle ocular fundus blood flow imaging device

Patent 7597443 was granted and assigned to Kyushu Institute of Technology on October, 2009 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Current Assignee
Kyushu Institute of Technology
Kyushu Institute of Technology
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
75974430
Patent Inventor Names
Naoki Konishi0
Hitoshi Fujii0
Date of Patent
October 6, 2009
0
Patent Application Number
116666060
Date Filed
October 27, 2005
0
Patent Primary Examiner
‌
Jordan M. Schwartz
0
Patent abstract

Provided is a wide viewing angle ocular fundus blood flow imaging device in which the measurement field of view is enlarged and which includes a projection system that turns a laser beam into a rectangular spot on the ocular fundus, an observation system that images the rectangular spot on an image sensor placed on the corresponding image plane, an observation optical system for carrying out positioning of the laser spot, and a mechanism for monitoring the movement of an ocular fundus blood vessel image.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7597443 Wide viewing angle ocular fundus blood flow imaging device

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.